![](/img/cover-not-exists.png)
[59] SUBSTANTIAL LOSS OF INTRAHEPATIC HBV cecDNA DURING ANTIVIRAL COMBINATION THERAPY TRANSLATES INTO LONG-TERM CLINICAL BENEFIT
M. Lutgehelmann, K. Wursthorn, M. Dandri, T. Volz, M. Zankel, C. Fischer, C. Brosgart, J. PetersenVolume:
46
Year:
2007
Language:
english
DOI:
10.1016/s0168-8278(07)61657-2
File:
PDF, 146 KB
english, 2007